Company Overview

iAnthus Capital Holdings, Inc. is a cannabis company focused on the cultivation, processing, distribution, and retail sale of medical and adult-use cannabis products in the United States. The company operates in the regulated cannabis industry through a portfolio of state-level licenses, dispensaries, cultivation facilities, and branded products. Its business model has historically centered on vertically integrated cannabis operations, allowing it to participate across multiple stages of the cannabis value chain, including cultivation, manufacturing, wholesale distribution, and direct-to-consumer retail sales.

The company evolved through acquisitions and multi-state expansion following its formation in Canada and subsequent listing on the Canadian Securities Exchange. iAnthus expanded aggressively during the late 2010s through acquisitions including MPX Bioceutical Corporation, which significantly increased its operational footprint in the U.S. cannabis market. Following rapid expansion, the company underwent financial restructuring and recapitalization efforts beginning in 2020 amid liquidity challenges affecting the broader cannabis sector. Its strategic positioning has emphasized regulated U.S. cannabis markets with limited-license structures and vertically integrated operations.

Business Operations

iAnthus generates revenue primarily through retail cannabis sales, wholesale cannabis distribution, and the sale of branded cannabis products. The company has operated through state-level subsidiaries and licensed entities across multiple U.S. jurisdictions, with activities including cultivation, extraction, product manufacturing, and dispensary operations. Key operational markets have included Florida, Massachusetts, Maryland, New York, New Jersey, and Arizona, although operational scale and active market presence have varied over time due to restructuring initiatives and asset optimization efforts.

The company has historically managed a portfolio of cannabis retail brands and production assets through subsidiaries and licensed operators. Its operations have included dispensaries under various retail banners as well as cultivation and processing facilities designed to support vertically integrated supply chains. iAnthus has also maintained relationships with local operating partners and state-licensed entities where required by regulatory structures. Data regarding certain current operational assets and active license counts is inconclusive based on available public sources due to restructuring activity and evolving state disclosures.

Strategic Position & Investments

iAnthus has focused its strategic direction on operational stabilization, balance sheet restructuring, and optimization of core cannabis assets in limited-license U.S. markets. Following its financial restructuring, the company emphasized improving operating efficiency, streamlining overhead costs, and concentrating resources on higher-performing markets and retail operations. The company’s prior acquisition strategy sought to establish a national multi-state cannabis platform with vertically integrated capabilities across cultivation, manufacturing, and retail distribution.

A major strategic transaction in the company’s history was the acquisition of MPX Bioceutical Corporation, which materially expanded iAnthus’s cultivation and dispensary footprint. The company has also invested in cannabis brands, processing capabilities, and retail expansion initiatives in regulated U.S. jurisdictions. Its broader strategic exposure remains tied to the growth of legalized medical and adult-use cannabis markets in the United States, including opportunities related to evolving state regulations and potential federal policy developments affecting the cannabis sector.

Geographic Footprint

iAnthus Capital Holdings is headquartered in New York, United States, and has historically maintained operations across several regulated U.S. cannabis markets. Its operational presence has included cultivation facilities, processing assets, and retail dispensaries concentrated in states with medical and adult-use cannabis programs. The company’s market footprint has primarily focused on the United States, rather than international cannabis operations.

The company’s strongest historical presence has been in the Northeastern United States and selected growth markets in the Southwest and Southeast. Operations have included activities in Florida, Massachusetts, New York, Maryland, New Jersey, and Arizona, among others. While iAnthus is publicly traded in Canada, its business operations and revenue generation have been overwhelmingly tied to U.S. cannabis markets and state-regulated cannabis licensing frameworks.

Leadership & Governance

iAnthus was co-founded by Hadley Ford and Randy Maslow, who helped establish the company’s early strategy as a multi-state cannabis operator focused on regulated U.S. markets. Leadership direction over time has centered on expansion through acquisitions, vertical integration, and later financial restructuring and operational stabilization following industry-wide market pressures in the cannabis sector.

Key executives and leadership figures associated with the company have included:

• Hadley Ford – Co-Founder and Former Chief Executive Officer
• Randy Maslow – Co-Founder and Former Vice Chairman
• Robert Galvin – Former Interim Chief Executive Officer
• Larry Siegler – Former Chief Executive Officer and Director
• Julius Kalcevich – Chief Financial Officer

The company’s governance approach has emphasized restructuring oversight, operational efficiency, and regulatory compliance within highly regulated state cannabis markets. Public disclosures, including Canadian securities filings and restructuring-related communications, indicate that management priorities have included preserving liquidity, improving operational performance, and maintaining compliance with evolving cannabis regulations.